• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
AC8
Click for more information
1.92% 13.3¢

AUSCANN GROUP HOLDINGS LTD - Announcements

Currently unlisted. watchlist Created with Sketch. Add to my watchlist

AusCann Group Holdings Ltd, formerly TW Holdings Limited, is an Australia-based company,... AusCann Group Holdings Ltd, formerly TW Holdings Limited, is an Australia-based company, which is engaged in the medical marijuana cultivation and distribution. The Company is in the process of researching and obtaining licenses for growing and distributions rights, as well as developing appropriate cultivation methods. The Company focuses on investigating other opportunities in the medical cannabis sector, including acquisition or investment in other international plant breeders, producers and suppliers.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW

Filter Results
All Price Sensitive Only
search Created with Sketch. Search
search Created with Sketch. Search
Filters [Clear]
  • Price Sensitive: Yes
AC8 S&P DJI Announces March 2019 Quarterly RebalancePRICE SENSITIVE08/03/19
AC8 Investor PresentationPRICE SENSITIVE07/03/19
AC8 Appendix 4D and Half-Year Financial Report 31 December 2018PRICE SENSITIVE28/02/19
AC8 AC8 Appoints Experienced Global Pharma Executive as New CEOPRICE SENSITIVE25/02/19
AC8 AusCann Signs Cannabis Resin Supply Agreement with MediPharmPRICE SENSITIVE21/02/19
AC8 December 2018 Quarterly Activities and Cashflow ReportPRICE SENSITIVE31/01/19
AC8 AusCann Establishes Research and Development FacilityPRICE SENSITIVE25/01/19
AC8 AusCann JV commences first cultivation activity with KhironPRICE SENSITIVE22/01/19
AC8 AusCann Leadership Transition UpdatePRICE SENSITIVE17/12/18
AC8 AC8 Moves First Products to Commercial Manufacturing SitePRICE SENSITIVE13/11/18
AC8 September 2018 Quarterly Activities and Cashflow ReportPRICE SENSITIVE30/10/18
AC8 AusCann Joint Venture Signs MoU with Khiron Life SciencesPRICE SENSITIVE01/10/18
AC8 AusCann Announces Leadership TransitionPRICE SENSITIVE27/09/18
AC8 Appendix 4E and Preliminary Final ReportPRICE SENSITIVE31/08/18
AC8 Successful Pilot Study of Final Dose Cannabinoid CapsulesPRICE SENSITIVE16/08/18
AC8 AusCann Share Purchase Plan Raises $1.9mPRICE SENSITIVE09/08/18
AC8 June 2018 Quarterly Activities and Cashflow ReportPRICE SENSITIVE31/07/18
AC8 Response to ASX Aware QueryPRICE SENSITIVE19/07/18 download Created with Sketch. 742.64KB
AC8 AusCann Share Purchase PlanPRICE SENSITIVE16/07/18 download Created with Sketch. 140.61KB
AC8 AusCann Completes A$33.4 million PlacementPRICE SENSITIVE05/07/18 download Created with Sketch. 144.31KB
AC8 Trading HaltPRICE SENSITIVE03/07/18 download Created with Sketch. 161.42KB
AC8 Australian Production Accelerates with Canadian EngagementsPRICE SENSITIVE25/06/18 download Created with Sketch. 129.73KB
AC8 Response to ASX Price and Volume QueryPRICE SENSITIVE20/06/18 download Created with Sketch. 472.66KB
AC8 AusCann Joint Venture Harvests Second Crop in ChilePRICE SENSITIVE07/06/18 download Created with Sketch. 711.89KB
AC8 March 2018 Quarterly Activities and Cashflow ReportPRICE SENSITIVE26/04/18
AC8 AusCann and Canopy Growth Partnership ExpansionPRICE SENSITIVE24/04/18
AC8 Immediate access for Chilean patientsPRICE SENSITIVE28/03/18
AC8 Appendix 4D and 31 December 2017 Half Year ReportPRICE SENSITIVE28/02/18
AC8 December 2017 Quarterly Activities and Cashflow ReportsPRICE SENSITIVE31/01/18
AC8 HoA signed with Leading Wholesale Distributor in AustraliaPRICE SENSITIVE22/01/18
AC8 Federal Government to Allow Cannabis ExportPRICE SENSITIVE04/01/18
AC8 AusCann Plants Second Crop in ChilePRICE SENSITIVE18/12/17
AC8 Final Operational Licence Now in PlacePRICE SENSITIVE07/12/17
AC8 Trading HaltPRICE SENSITIVE06/12/17
AC8 Chilean Cultivation Licence Secured for Second CropPRICE SENSITIVE22/11/17
AC8 Trading HaltPRICE SENSITIVE21/11/17
AC8 September 2017 Quarterly Activities and Cashflow ReportPRICE SENSITIVE31/10/17
AC8 Appendix 4E and Preliminary Final ReportPRICE SENSITIVE31/08/17
AC8 Australian Manufacturing Licence GrantedPRICE SENSITIVE09/08/17
AC8 Trading HaltPRICE SENSITIVE07/08/17
AC8 June 2017 Quarterly Activities and Cashflow ReportPRICE SENSITIVE31/07/17
AC8 Auscann - Tasmanian Alkaloids Licences SecuredPRICE SENSITIVE11/07/17
AC8 Improved Access For Critically Ill PatientsPRICE SENSITIVE14/06/17
AC8 Cleansing ProspectusPRICE SENSITIVE23/05/17
AC8 AusCann Secures $12 Million in Institutional PlacementPRICE SENSITIVE19/05/17
AC8 Response to Media Commentary on Proposed Capital RaisingPRICE SENSITIVE18/05/17
AC8 Trading HaltPRICE SENSITIVE17/05/17
AC8 AusCann - Tasmanian Alkaloids Strategic PartnershipPRICE SENSITIVE17/05/17
AC8 Medicinal Cannabis Licence SecuredPRICE SENSITIVE05/05/17
AC8 Trading HaltPRICE SENSITIVE04/05/17
AC8 March 2017 Quarterly Activities and Cashflow ReportPRICE SENSITIVE28/04/17
AC8 First Crop Harvested In ChilePRICE SENSITIVE10/04/17
AC8 Appendix 4D and Half Year Financial ReportPRICE SENSITIVE28/02/17
AC8 Government to Facilitate Faster Access to Medical CannabisPRICE SENSITIVE23/02/17
AC8 First Crop to be Harvested in ChilePRICE SENSITIVE16/02/17
AC8 Reinstatement to Official Quotation - 3 February 2017PRICE SENSITIVE01/02/17
AC8 S&P DJI Announces March 2019 Quarterly Rebalance
08/03/19PRICE SENSITIVE
AC8 Investor Presentation
07/03/19PRICE SENSITIVE
AC8 Appendix 4D and Half-Year Financial Report 31 December 2018
28/02/19PRICE SENSITIVE
AC8 AC8 Appoints Experienced Global Pharma Executive as New CEO
25/02/19PRICE SENSITIVE
AC8 AusCann Signs Cannabis Resin Supply Agreement with MediPharm
21/02/19PRICE SENSITIVE
AC8 December 2018 Quarterly Activities and Cashflow Report
31/01/19PRICE SENSITIVE
AC8 AusCann Establishes Research and Development Facility
25/01/19PRICE SENSITIVE
AC8 AusCann JV commences first cultivation activity with Khiron
22/01/19PRICE SENSITIVE
AC8 AusCann Leadership Transition Update
17/12/18PRICE SENSITIVE
AC8 AC8 Moves First Products to Commercial Manufacturing Site
13/11/18PRICE SENSITIVE
AC8 September 2018 Quarterly Activities and Cashflow Report
30/10/18PRICE SENSITIVE
AC8 AusCann Joint Venture Signs MoU with Khiron Life Sciences
01/10/18PRICE SENSITIVE
AC8 AusCann Announces Leadership Transition
27/09/18PRICE SENSITIVE
AC8 Appendix 4E and Preliminary Final Report
31/08/18PRICE SENSITIVE
AC8 Successful Pilot Study of Final Dose Cannabinoid Capsules
16/08/18PRICE SENSITIVE
AC8 AusCann Share Purchase Plan Raises $1.9m
09/08/18PRICE SENSITIVE
AC8 June 2018 Quarterly Activities and Cashflow Report
31/07/18PRICE SENSITIVE
AC8 Response to ASX Aware Query
19/07/18PRICE SENSITIVE download Created with Sketch. 742.64KB
AC8 AusCann Share Purchase Plan
16/07/18PRICE SENSITIVE download Created with Sketch. 140.61KB
AC8 AusCann Completes A$33.4 million Placement
05/07/18PRICE SENSITIVE download Created with Sketch. 144.31KB
AC8 Trading Halt
03/07/18PRICE SENSITIVE download Created with Sketch. 161.42KB
AC8 Australian Production Accelerates with Canadian Engagements
25/06/18PRICE SENSITIVE download Created with Sketch. 129.73KB
AC8 Response to ASX Price and Volume Query
20/06/18PRICE SENSITIVE download Created with Sketch. 472.66KB
AC8 AusCann Joint Venture Harvests Second Crop in Chile
07/06/18PRICE SENSITIVE download Created with Sketch. 711.89KB
AC8 March 2018 Quarterly Activities and Cashflow Report
26/04/18PRICE SENSITIVE
AC8 AusCann and Canopy Growth Partnership Expansion
24/04/18PRICE SENSITIVE
AC8 Immediate access for Chilean patients
28/03/18PRICE SENSITIVE
AC8 Appendix 4D and 31 December 2017 Half Year Report
28/02/18PRICE SENSITIVE
AC8 December 2017 Quarterly Activities and Cashflow Reports
31/01/18PRICE SENSITIVE
AC8 HoA signed with Leading Wholesale Distributor in Australia
22/01/18PRICE SENSITIVE
AC8 Federal Government to Allow Cannabis Export
04/01/18PRICE SENSITIVE
AC8 AusCann Plants Second Crop in Chile
18/12/17PRICE SENSITIVE
AC8 Final Operational Licence Now in Place
07/12/17PRICE SENSITIVE
AC8 Trading Halt
06/12/17PRICE SENSITIVE
AC8 Chilean Cultivation Licence Secured for Second Crop
22/11/17PRICE SENSITIVE
AC8 Trading Halt
21/11/17PRICE SENSITIVE
AC8 September 2017 Quarterly Activities and Cashflow Report
31/10/17PRICE SENSITIVE
AC8 Appendix 4E and Preliminary Final Report
31/08/17PRICE SENSITIVE
AC8 Australian Manufacturing Licence Granted
09/08/17PRICE SENSITIVE
AC8 Trading Halt
07/08/17PRICE SENSITIVE
AC8 June 2017 Quarterly Activities and Cashflow Report
31/07/17PRICE SENSITIVE
AC8 Auscann - Tasmanian Alkaloids Licences Secured
11/07/17PRICE SENSITIVE
AC8 Improved Access For Critically Ill Patients
14/06/17PRICE SENSITIVE
AC8 Cleansing Prospectus
23/05/17PRICE SENSITIVE
AC8 AusCann Secures $12 Million in Institutional Placement
19/05/17PRICE SENSITIVE
AC8 Response to Media Commentary on Proposed Capital Raising
18/05/17PRICE SENSITIVE
AC8 Trading Halt
17/05/17PRICE SENSITIVE
AC8 AusCann - Tasmanian Alkaloids Strategic Partnership
17/05/17PRICE SENSITIVE
AC8 Medicinal Cannabis Licence Secured
05/05/17PRICE SENSITIVE
AC8 Trading Halt
04/05/17PRICE SENSITIVE
AC8 March 2017 Quarterly Activities and Cashflow Report
28/04/17PRICE SENSITIVE
AC8 First Crop Harvested In Chile
10/04/17PRICE SENSITIVE
AC8 Appendix 4D and Half Year Financial Report
28/02/17PRICE SENSITIVE
AC8 Government to Facilitate Faster Access to Medical Cannabis
23/02/17PRICE SENSITIVE
AC8 First Crop to be Harvested in Chile
16/02/17PRICE SENSITIVE
AC8 Reinstatement to Official Quotation - 3 February 2017
01/02/17PRICE SENSITIVE
refresh Created with Sketch. REFRESH
 

Top Stories

Scientific conference spotlights PYC's work on blindness disease treatment

PYC Therapeutics Ltd will have data from its ongoing trial into a drug candidate to treat Retinitis Pigmentosa type 11 presented in Singapore
Panic, paranoia, and gangland politics: HotCopper users react to Dubber's missing $26M HotCopper users have reacted to overnight reports Dubber has seen $26M disappear from its coffers due to organised crime links.
Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing Bigtincan Holdings has fielded an offer from Investcorp. But if you think it's underwhelming – consider Wall Street volumes.
HotCopper Highlights: Your most watched stocks for Week 47, 2024 In this segment we’ll look at the top stocks HotCopper users have been watching, and discussing, through Week 47. Let’s get into it. 
Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects Pan Asia Metals has scored $35 million from a New York private equity firm at the same time as the company's big rebrand push begins.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.